V CompBrief BY VELARION

Independent Director · TScan Therapeutics, Inc. (TCRX)

Chair, Nominating/Governance Committee

Garry Nicholson director compensation at TScan Therapeutics: $125K

Fiscal year 2025 director compensation for Garry Nicholson at TScan Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Garry Nicholson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Garry Nicholson and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

TScan Therapeutics Director Compensation Table · all 2 fiscal years held
In US dollars, as TScan Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$53,740$0$71,623$0$125,363
FY2024$27,045—$464,377$0$491,421

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TScan Therapeutics, Inc. DEF 14A filed April 17, 2026, accession 0001193125-26-160304, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TScan Therapeutics, Inc. filed document, accession 0001193125-26-160304. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the TScan Therapeutics Board Governance Report

$125,363 Garry Nicholson, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

TScan Therapeutics pays directors a $40,000 cash retainer and $71,623 in equity.

Committees

FY2025 · as the proxy prints them

Nominating/Governance (Chair) · Research and Clinical Development

The rest of the TScan Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Barbara Klencke, M.DIndependent Director$145,779
Gabriela Gruia, M.DIndependent Director$129,122
Gavin MacBeath, Ph.DDirector—
Katina Dorton, J.D., M.B.AIndependent Director$139,109
R. Keith WoodsIndependent Director$125,265
Stephen Biggar, M.D., Ph.DChair of the Board$162,232

The full TScan Therapeutics compensation record

free company brief
TScan Therapeutics, Inc. (TCRX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within TScan Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order TCRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report